메뉴 건너뛰기




Volumn 2, Issue 5, 2013, Pages 382-397

Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers

Author keywords

Biomarker; Circulating; Early stage; Non small cell lung cancer (NSCLC); Predictive; Prognostic

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; DNA; FIBRINOGEN; MESSENGER RNA; MICRORNA; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

EID: 84924286661     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2013.09.02     Document Type: Review
Times cited : (39)

References (115)
  • 2
    • 79961108629 scopus 로고    scopus 로고
    • Reduced lung-cancer mortality with low-dose computed tomographic screening
    • National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
    • (2011) N Engl J Med , vol.365 , pp. 395-409
    • Aberle, D.R.1    Adams, A.M.2
  • 3
    • 34548457234 scopus 로고    scopus 로고
    • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
    • Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14.
    • (2007) J Thorac Oncol , vol.2 , pp. 706-714
    • Goldstraw, P.1    Crowley, J.2    Chansky, K.3
  • 4
    • 7544238774 scopus 로고    scopus 로고
    • Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type
    • Choi YS, Shim YM, Kim K, et al. Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type. J Korean Med Sci 2004;19:674-6.
    • (2004) J Korean Med Sci , vol.19 , pp. 674-676
    • Choi, Y.S.1    Shim, Y.M.2    Kim, K.3
  • 5
    • 77649114560 scopus 로고    scopus 로고
    • Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure
    • Boyd JA, Hubbs JL, Kim DW, et al. Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure. J Thorac Oncol 2010;5:211-4.
    • (2010) J Thorac Oncol , vol.5 , pp. 211-214
    • Boyd, J.A.1    Hubbs, J.L.2    Kim, D.W.3
  • 6
    • 49049109683 scopus 로고    scopus 로고
    • Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
    • Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-9.
    • (2008) J Clin Oncol , vol.26 , pp. 3552-3559
    • Pignon, J.P.1    Tribodet, H.2    Scagliotti, G.V.3
  • 7
    • 77950520452 scopus 로고    scopus 로고
    • Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
    • NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010;375:1267-77.
    • (2010) Lancet , vol.375 , pp. 1267-1277
    • Arriagada, R.1    Auperin, A.2
  • 8
    • 45949090453 scopus 로고    scopus 로고
    • Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients
    • Tomita M, Shimizu T, Hara M, et al. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients. Anticancer Res 2008;28:1947-50.
    • (2008) Anticancer Res , vol.28 , pp. 1947-1950
    • Tomita, M.1    Shimizu, T.2    Hara, M.3
  • 9
    • 84878970558 scopus 로고    scopus 로고
    • Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome
    • Carus A, Ladekarl M, Hager H, et al. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome. Lung Cancer 2013;81:130-7.
    • (2013) Lung Cancer , vol.81 , pp. 130-137
    • Carus, A.1    Ladekarl, M.2    Hager, H.3
  • 10
    • 84855464641 scopus 로고    scopus 로고
    • Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer
    • Kobayashi N, Usui S, Kikuchi S, et al. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer 2012;75:223-7.
    • (2012) Lung Cancer , vol.75 , pp. 223-227
    • Kobayashi, N.1    Usui, S.2    Kikuchi, S.3
  • 11
    • 84871588769 scopus 로고    scopus 로고
    • Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer
    • Zhang J, Huang SH, Li H, et al. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol 2013;30:352.
    • (2013) Med Oncol , vol.30 , pp. 352
    • Zhang, J.1    Huang, S.H.2    Li, H.3
  • 12
    • 58649105512 scopus 로고    scopus 로고
    • Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
    • Sarraf KM, Belcher E, Raevsky E, et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:425-8.
    • (2009) J Thorac Cardiovasc Surg , vol.137 , pp. 425-428
    • Sarraf, K.M.1    Belcher, E.2    Raevsky, E.3
  • 13
    • 84876561105 scopus 로고    scopus 로고
    • Platelet count predicts prognosis in operable non-small cell lung cancer
    • Yu D, Liu B, Zhang L, et al. Platelet count predicts prognosis in operable non-small cell lung cancer. Exp Ther Med 2013;5:1351-54.
    • (2013) Exp Ther Med , vol.5 , pp. 1351-1354
    • Yu, D.1    Liu, B.2    Zhang, L.3
  • 14
    • 78649670813 scopus 로고    scopus 로고
    • Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in nonsmall-cell lung cancer
    • Tomita M, Shimizu T, Ayabe T, et al. Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in nonsmall-cell lung cancer. Gen Thorac Cardiovasc Surg 2010;58:573-6.
    • (2010) Gen Thorac Cardiovasc Surg , vol.58 , pp. 573-576
    • Tomita, M.1    Shimizu, T.2    Ayabe, T.3
  • 15
    • 0033057177 scopus 로고    scopus 로고
    • The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
    • Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999;9:67-81.
    • (1999) Semin Cancer Biol , vol.9 , pp. 67-81
    • Hammarstrom, S.1
  • 16
    • 84859435256 scopus 로고    scopus 로고
    • Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
    • Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 2012;76:138-43.
    • (2012) Lung Cancer , vol.76 , pp. 138-143
    • Grunnet, M.1    Sorensen, J.B.2
  • 17
    • 85027937669 scopus 로고    scopus 로고
    • Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: Differences according to histology and smoking status
    • Kato T, Ishikawa K, Aragaki M, et al. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: Differences according to histology and smoking status. J Surg Oncol 2013;107:619-24.
    • (2013) J Surg Oncol , vol.107 , pp. 619-624
    • Kato, T.1    Ishikawa, K.2    Aragaki, M.3
  • 18
    • 84876723540 scopus 로고    scopus 로고
    • Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer
    • Kozu Y, Maniwa T, Takahashi S, et al. Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer. J Cardiothorac Surg 2013;8:106.
    • (2013) J Cardiothorac Surg , vol.8 , pp. 106
    • Kozu, Y.1    Maniwa, T.2    Takahashi, S.3
  • 19
    • 84876343411 scopus 로고    scopus 로고
    • High serum CEA and CYFRA21-1 levels after a two-cycle adjuvant chemotherapy for NSCLC: possible poor prognostic factors
    • Lin XF, Wang XD, Sun DQ, et al. High serum CEA and CYFRA21-1 levels after a two-cycle adjuvant chemotherapy for NSCLC: possible poor prognostic factors. Cancer Biol Med 2012;9:270-3.
    • (2012) Cancer Biol Med , vol.9 , pp. 270-273
    • Lin, X.F.1    Wang, X.D.2    Sun, D.Q.3
  • 20
    • 84877125043 scopus 로고    scopus 로고
    • A clinicopathological study of resected small-sized squamous cell carcinomas of the peripheral lung: prognostic significance of serum carcinoembryonic antigen levels
    • [Epub ahead of print]
    • Nagashima T, Sakao Y, Mun M, et al. A clinicopathological study of resected small-sized squamous cell carcinomas of the peripheral lung: prognostic significance of serum carcinoembryonic antigen levels. Ann Thorac Cardiovasc Surg 2012. [Epub ahead of print].
    • (2012) Ann Thorac Cardiovasc Surg
    • Nagashima, T.1    Sakao, Y.2    Mun, M.3
  • 21
    • 84865431357 scopus 로고    scopus 로고
    • Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
    • Tomita M, Shimizu T, Ayabe T, et al. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer. Asia Pac J Clin Oncol 2012;8:244-7.
    • (2012) Asia Pac J Clin Oncol , vol.8 , pp. 244-247
    • Tomita, M.1    Shimizu, T.2    Ayabe, T.3
  • 22
    • 80052585537 scopus 로고    scopus 로고
    • Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer
    • Hanagiri T, Sugaya M, Takenaka M, et al. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer. Lung Cancer 2011;74:112-7.
    • (2011) Lung Cancer , vol.74 , pp. 112-117
    • Hanagiri, T.1    Sugaya, M.2    Takenaka, M.3
  • 23
    • 81755166609 scopus 로고    scopus 로고
    • Prognosis of surgically resected lung cancer with extremely high preoperative serum carcinoembryonic antigen level
    • Takahashi N, Suzuki K, Takamochi K, et al. Prognosis of surgically resected lung cancer with extremely high preoperative serum carcinoembryonic antigen level. Gen Thorac Cardiovasc Surg 2011;59:699-704.
    • (2011) Gen Thorac Cardiovasc Surg , vol.59 , pp. 699-704
    • Takahashi, N.1    Suzuki, K.2    Takamochi, K.3
  • 24
    • 67650760768 scopus 로고    scopus 로고
    • Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level
    • Tomita M, Shimizu T, Hara M, et al. Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level. Gen Thorac Cardiovasc Surg 2009;57:303-6.
    • (2009) Gen Thorac Cardiovasc Surg , vol.57 , pp. 303-306
    • Tomita, M.1    Shimizu, T.2    Hara, M.3
  • 25
    • 51049102813 scopus 로고    scopus 로고
    • Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score
    • Blankenburg F, Hatz R, Nagel D, et al. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score. Tumour Biol 2008;29:272-7.
    • (2008) Tumour Biol , vol.29 , pp. 272-277
    • Blankenburg, F.1    Hatz, R.2    Nagel, D.3
  • 26
    • 61449494426 scopus 로고    scopus 로고
    • Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer
    • Kashiwabara K, Saeki S, Sasaki J, et al. Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer. J Thorac Oncol 2008;3:1416-20.
    • (2008) J Thorac Oncol , vol.3 , pp. 1416-1420
    • Kashiwabara, K.1    Saeki, S.2    Sasaki, J.3
  • 27
    • 37549027584 scopus 로고    scopus 로고
    • Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis
    • Matsuguma H, Nakahara R, Igarashi S, et al. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg 2008;135:44-9.
    • (2008) J Thorac Cardiovasc Surg , vol.135 , pp. 44-49
    • Matsuguma, H.1    Nakahara, R.2    Igarashi, S.3
  • 28
    • 33846373650 scopus 로고    scopus 로고
    • Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer
    • Hsu WH, Huang CS, Hsu HS, et al. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg 2007;83:419-24.
    • (2007) Ann Thorac Surg , vol.83 , pp. 419-424
    • Hsu, W.H.1    Huang, C.S.2    Hsu, H.S.3
  • 29
    • 34548385630 scopus 로고    scopus 로고
    • Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less
    • Kobayashi N, Toyooka S, Soh J, et al. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol 2007;2:808-12.
    • (2007) J Thorac Oncol , vol.2 , pp. 808-812
    • Kobayashi, N.1    Toyooka, S.2    Soh, J.3
  • 30
    • 34547676038 scopus 로고    scopus 로고
    • Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer
    • Matsuoka K, Sumitomo S, Nakashima N, et al. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:435-9.
    • (2007) Eur J Cardiothorac Surg , vol.32 , pp. 435-439
    • Matsuoka, K.1    Sumitomo, S.2    Nakashima, N.3
  • 31
    • 35748940008 scopus 로고    scopus 로고
    • Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer
    • Mizuguchi S, Nishiyama N, Iwata T, et al. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer 2007;58:369-75.
    • (2007) Lung Cancer , vol.58 , pp. 369-375
    • Mizuguchi, S.1    Nishiyama, N.2    Iwata, T.3
  • 32
    • 3242725210 scopus 로고    scopus 로고
    • CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients
    • Muley T, Dienemann H, Ebert W. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res 2004;24:1953-6.
    • (2004) Anticancer Res , vol.24 , pp. 1953-1956
    • Muley, T.1    Dienemann, H.2    Ebert, W.3
  • 33
    • 3042630511 scopus 로고    scopus 로고
    • Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1, 000 consecutive resections for clinical stage I disease
    • Okada M, Nishio W, Sakamoto T, et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1, 000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004;78:216-21.
    • (2004) Ann Thorac Surg , vol.78 , pp. 216-221
    • Okada, M.1    Nishio, W.2    Sakamoto, T.3
  • 34
    • 4444379030 scopus 로고    scopus 로고
    • Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma
    • discussion 1009-10
    • Okada M, Nishio W, Sakamoto T, et al. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Ann Thorac Surg 2004;78:1004-9; discussion 1009-10.
    • (2004) Ann Thorac Surg , vol.78 , pp. 1004-1009
    • Okada, M.1    Nishio, W.2    Sakamoto, T.3
  • 35
    • 1642396530 scopus 로고    scopus 로고
    • Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma
    • Sakao Y, Tomimitsu S, Takeda Y, et al. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 2004;25:520-2.
    • (2004) Eur J Cardiothorac Surg , vol.25 , pp. 520-522
    • Sakao, Y.1    Tomimitsu, S.2    Takeda, Y.3
  • 36
    • 3242697157 scopus 로고    scopus 로고
    • Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma
    • Tomita M, Matsuzaki Y, Edagawa M, et al. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2004;10:76-80.
    • (2004) Ann Thorac Cardiovasc Surg , vol.10 , pp. 76-80
    • Tomita, M.1    Matsuzaki, Y.2    Edagawa, M.3
  • 37
    • 0037335077 scopus 로고    scopus 로고
    • Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test
    • Buccheri G, Ferrigno D. Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg 2003;75:973-80.
    • (2003) Ann Thorac Surg , vol.75 , pp. 973-980
    • Buccheri, G.1    Ferrigno, D.2
  • 38
    • 0036257505 scopus 로고    scopus 로고
    • Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
    • Reinmuth N, Brandt B, Semik M, et al. Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer 2002;36:265-70.
    • (2002) Lung Cancer , vol.36 , pp. 265-270
    • Reinmuth, N.1    Brandt, B.2    Semik, M.3
  • 39
    • 0036301507 scopus 로고    scopus 로고
    • Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer
    • Sawabata N, Ohta M, Takeda S, et al. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002;74:174-9.
    • (2002) Ann Thorac Surg , vol.74 , pp. 174-179
    • Sawabata, N.1    Ohta, M.2    Takeda, S.3
  • 40
    • 0033877729 scopus 로고    scopus 로고
    • Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinicalstage I patients with non-small-cell lung cancer
    • Hotta K, Segawa Y, Takigawa N, et al. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinicalstage I patients with non-small-cell lung cancer. Anticancer Res 2000;20:2177-80.
    • (2000) Anticancer Res , vol.20 , pp. 2177-2180
    • Hotta, K.1    Segawa, Y.2    Takigawa, N.3
  • 41
    • 0032915271 scopus 로고    scopus 로고
    • Prognostic factors in clinical stage I non-small cell lung cancer
    • Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999;67:927-32.
    • (1999) Ann Thorac Surg , vol.67 , pp. 927-932
    • Suzuki, K.1    Nagai, K.2    Yoshida, J.3
  • 42
    • 0031662707 scopus 로고    scopus 로고
    • Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer
    • Rubins JB, Dunitz J, Rubins HB, et al. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 1998;116:412-6.
    • (1998) J Thorac Cardiovasc Surg , vol.116 , pp. 412-416
    • Rubins, J.B.1    Dunitz, J.2    Rubins, H.B.3
  • 43
    • 0028020732 scopus 로고
    • Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer
    • Icard P, Regnard JF, Essomba A, et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 1994;58:811-4.
    • (1994) Ann Thorac Surg , vol.58 , pp. 811-814
    • Icard, P.1    Regnard, J.F.2    Essomba, A.3
  • 44
    • 0019489518 scopus 로고
    • Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels
    • Ford CH, Stokes HJ, Newman CE. Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels. Br J Cancer 1981;44:145-53.
    • (1981) Br J Cancer , vol.44 , pp. 145-153
    • Ford, C.H.1    Stokes, H.J.2    Newman, C.E.3
  • 45
    • 0032825566 scopus 로고    scopus 로고
    • Cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma
    • Kao CH, Hsieh JF, Ho YJ, et al. Cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma. Lung 1999;177:333-7.
    • (1999) Lung , vol.177 , pp. 333-337
    • Kao, C.H.1    Hsieh, J.F.2    Ho, Y.J.3
  • 46
    • 0033455515 scopus 로고    scopus 로고
    • Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
    • Nisman B, Amir G, Lafair J, et al. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Res 1999;19:3549-52.
    • (1999) Anticancer Res , vol.19 , pp. 3549-3552
    • Nisman, B.1    Amir, G.2    Lafair, J.3
  • 47
    • 0026937685 scopus 로고
    • Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer
    • Niklinski J, Furman M, Laudanski J, et al. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer. Eur J Cancer Prev 1992;1:401-6.
    • (1992) Eur J Cancer Prev , vol.1 , pp. 401-406
    • Niklinski, J.1    Furman, M.2    Laudanski, J.3
  • 48
    • 0027380337 scopus 로고
    • Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer
    • Buccheri G, Ferrigno D, Vola F. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer. Lung Cancer 1993;10:21-33.
    • (1993) Lung Cancer , vol.10 , pp. 21-33
    • Buccheri, G.1    Ferrigno, D.2    Vola, F.3
  • 49
    • 0033428435 scopus 로고    scopus 로고
    • Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer
    • Foa P, Fornier M, Miceli R, et al. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Res 1999;19:3613-8.
    • (1999) Anticancer Res , vol.19 , pp. 3613-3618
    • Foa, P.1    Fornier, M.2    Miceli, R.3
  • 50
    • 0029008973 scopus 로고
    • Effect of cigarette smoke on the mRNA and protein expression of carcinoembryonic antigen (CEA), a possible chemoattractant for neutrophils in human bronchioloalveolar tissues
    • Ohwada A, Takahashi H, Nagaoka I, et al. Effect of cigarette smoke on the mRNA and protein expression of carcinoembryonic antigen (CEA), a possible chemoattractant for neutrophils in human bronchioloalveolar tissues. Thorax 1995;50:651-7.
    • (1995) Thorax , vol.50 , pp. 651-657
    • Ohwada, A.1    Takahashi, H.2    Nagaoka, I.3
  • 51
    • 0035191105 scopus 로고    scopus 로고
    • Lung tumor markers of cytokeratin origin: an overview
    • Buccheri G, Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer 2001;34 Suppl 2:S65-9.
    • (2001) Lung Cancer , vol.34 , pp. S65-S69
    • Buccheri, G.1    Ferrigno, D.2
  • 53
    • 0023947997 scopus 로고
    • Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies
    • Broers JL, Ramaekers FC, Rot MK, et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 1988;48:3221-9.
    • (1988) Cancer Res , vol.48 , pp. 3221-3229
    • Broers, J.L.1    Ramaekers, F.C.2    Rot, M.K.3
  • 54
    • 0036841417 scopus 로고    scopus 로고
    • Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients
    • Kulpa J, Wojcik E, Reinfuss M, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem 2002;48:1931-7.
    • (2002) Clin Chem , vol.48 , pp. 1931-1937
    • Kulpa, J.1    Wojcik, E.2    Reinfuss, M.3
  • 55
    • 0035145078 scopus 로고    scopus 로고
    • Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients
    • Pujol JL, Boher JM, Grenier J, et al. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Lung Cancer 2001;31:221-31.
    • (2001) Lung Cancer , vol.31 , pp. 221-231
    • Pujol, J.L.1    Boher, J.M.2    Grenier, J.3
  • 56
    • 3042710800 scopus 로고    scopus 로고
    • CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
    • Pujol JL, Molinier O, Ebert W, et al. CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients. Br J Cancer 2004;90:2097-105.
    • (2004) Br J Cancer , vol.90 , pp. 2097-2105
    • Pujol, J.L.1    Molinier, O.2    Ebert, W.3
  • 57
    • 77955813916 scopus 로고    scopus 로고
    • Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer
    • Tomita M, Shimizu T, Ayabe T, et al. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer. Anticancer Res 2010;30:3099-102.
    • (2010) Anticancer Res , vol.30 , pp. 3099-3102
    • Tomita, M.1    Shimizu, T.2    Ayabe, T.3
  • 58
    • 0031105977 scopus 로고    scopus 로고
    • Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients
    • Brechot JM, Chevret S, Nataf J, et al. Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Eur J Cancer 1997;33:385-91.
    • (1997) Eur J Cancer , vol.33 , pp. 385-391
    • Brechot, J.M.1    Chevret, S.2    Nataf, J.3
  • 59
    • 0037314212 scopus 로고    scopus 로고
    • Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
    • Pujol JL, Quantin X, Jacot W, et al. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 2003;39:131-8.
    • (2003) Lung Cancer , vol.39 , pp. 131-138
    • Pujol, J.L.1    Quantin, X.2    Jacot, W.3
  • 60
    • 84862844389 scopus 로고    scopus 로고
    • The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited
    • Ma S, Shen L, Qian N, et al. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Cancer Biomark 2011;10:155-62.
    • (2011) Cancer Biomark , vol.10 , pp. 155-162
    • Ma, S.1    Shen, L.2    Qian, N.3
  • 61
    • 84878444832 scopus 로고    scopus 로고
    • Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients
    • Yu D, Du K, Liu T, et al. Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients. Int J Mol Sci 2013;14:11145-56.
    • (2013) Int J Mol Sci , vol.14 , pp. 11145-11156
    • Yu, D.1    Du, K.2    Liu, T.3
  • 62
    • 34547761399 scopus 로고    scopus 로고
    • Preoperative serum C-reactive protein level in non-small cell lung cancer
    • Hara M, Matsuzaki Y, Shimuzu T, et al. Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 2007;27:3001-4.
    • (2007) Anticancer Res , vol.27 , pp. 3001-3004
    • Hara, M.1    Matsuzaki, Y.2    Shimuzu, T.3
  • 63
    • 77954428188 scopus 로고    scopus 로고
    • Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for nonsmall cell lung cancer
    • O'Dowd C, McRae LA, McMillan DC, et al. Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for nonsmall cell lung cancer. J Thorac Oncol 2010;5:988-92.
    • (2010) J Thorac Oncol , vol.5 , pp. 988-992
    • O'Dowd, C.1    McRae, L.A.2    McMillan, D.C.3
  • 64
    • 84884903581 scopus 로고    scopus 로고
    • Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer
    • Sheng L, Luo M, Sun X, et al. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer 2013;133:2720-5.
    • (2013) Int J Cancer , vol.133 , pp. 2720-2725
    • Sheng, L.1    Luo, M.2    Sun, X.3
  • 65
    • 0028963398 scopus 로고
    • Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer
    • Diez M, Gomez A, Hernando F, et al. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer. Int J Biol Markers 1995;10:5-10.
    • (1995) Int J Biol Markers , vol.10 , pp. 5-10
    • Diez, M.1    Gomez, A.2    Hernando, F.3
  • 66
    • 0028205226 scopus 로고
    • Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer
    • Diez M, Torres A, Pollan M, et al. Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer. Cancer 1994;73:1368-76.
    • (1994) Cancer , vol.73 , pp. 1368-1376
    • Diez, M.1    Torres, A.2    Pollan, M.3
  • 67
    • 0042529193 scopus 로고    scopus 로고
    • Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer
    • Gaspar MJ, Diez M, Rodriguez A, et al. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Anticancer Res 2003;23:3427-32.
    • (2003) Anticancer Res , vol.23 , pp. 3427-3432
    • Gaspar, M.J.1    Diez, M.2    Rodriguez, A.3
  • 68
    • 79957458567 scopus 로고    scopus 로고
    • Cell-free nucleic acids as biomarkers in cancer patients
    • Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-37.
    • (2011) Nat Rev Cancer , vol.11 , pp. 426-437
    • Schwarzenbach, H.1    Hoon, D.S.2    Pantel, K.3
  • 69
    • 20444374483 scopus 로고    scopus 로고
    • Circulating tumourderived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
    • Bremnes RM, Sirera R, Camps C. Circulating tumourderived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005;49:1-12.
    • (2005) Lung Cancer , vol.49 , pp. 1-12
    • Bremnes, R.M.1    Sirera, R.2    Camps, C.3
  • 70
    • 58349121421 scopus 로고    scopus 로고
    • Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study
    • Sozzi G, Roz L, Conte D, et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. Am J Respir Crit Care Med 2009;179:69-74.
    • (2009) Am J Respir Crit Care Med , vol.179 , pp. 69-74
    • Sozzi, G.1    Roz, L.2    Conte, D.3
  • 71
    • 77950459166 scopus 로고    scopus 로고
    • Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer
    • van der Drift MA, Hol BE, Klaassen CH, et al. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer. Lung Cancer 2010;68:283-7.
    • (2010) Lung Cancer , vol.68 , pp. 283-287
    • van der Drift, M.A.1    Hol, B.E.2    Klaassen, C.H.3
  • 72
    • 41749114329 scopus 로고    scopus 로고
    • Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology
    • Ludovini V, Pistola L, Gregorc V, et al. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology. J Thorac Oncol 2008;3:365-73.
    • (2008) J Thorac Oncol , vol.3 , pp. 365-373
    • Ludovini, V.1    Pistola, L.2    Gregorc, V.3
  • 73
    • 84861448570 scopus 로고    scopus 로고
    • Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC
    • Szpechcinski A, Chorostowska-Wynimko J, Kupis W, et al. Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC. Expert Opin Biol Ther 2012;12 Suppl 1:S3-9.
    • (2012) Expert Opin Biol Ther , vol.12 , pp. S3-S9
    • Szpechcinski, A.1    Chorostowska-Wynimko, J.2    Kupis, W.3
  • 74
    • 77956579573 scopus 로고    scopus 로고
    • MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis
    • Mallick R, Patnaik SK, Yendamuri S. MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. J Carcinog 2010;9:8.
    • (2010) J Carcinog , vol.9 , pp. 8
    • Mallick, R.1    Patnaik, S.K.2    Yendamuri, S.3
  • 75
    • 33645294070 scopus 로고    scopus 로고
    • Oncomirs-microRNAs with a role in cancer
    • Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
    • (2006) Nat Rev Cancer , vol.6 , pp. 259-269
    • Esquela-Kerscher, A.1    Slack, F.J.2
  • 76
    • 37349096992 scopus 로고    scopus 로고
    • MicroRNA signature predicts survival and relapse in lung cancer
    • Yu SL, Chen HY, Chang GC, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57.
    • (2008) Cancer Cell , vol.13 , pp. 48-57
    • Yu, S.L.1    Chen, H.Y.2    Chang, G.C.3
  • 77
    • 48749122914 scopus 로고    scopus 로고
    • Circulating microRNAs as stable blood-based markers for cancer detection
    • Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 10513-10518
    • Mitchell, P.S.1    Parkin, R.K.2    Kroh, E.M.3
  • 78
    • 77950498821 scopus 로고    scopus 로고
    • Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer
    • Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-6.
    • (2010) J Clin Oncol , vol.28 , pp. 1721-1726
    • Hu, Z.1    Chen, X.2    Zhao, Y.3
  • 79
    • 84977478146 scopus 로고    scopus 로고
    • MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
    • Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011;108:3713-8.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 3713-3718
    • Boeri, M.1    Verri, C.2    Conte, D.3
  • 80
    • 84880636323 scopus 로고    scopus 로고
    • Prognostic significance of serum miR-17-5p in lung cancer
    • Chen Q, Si Q, Xiao S, et al. Prognostic significance of serum miR-17-5p in lung cancer. Med Oncol 2013;30:353.
    • (2013) Med Oncol , vol.30 , pp. 353
    • Chen, Q.1    Si, Q.2    Xiao, S.3
  • 81
    • 84856117899 scopus 로고    scopus 로고
    • Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
    • Heegaard NH, Schetter AJ, Welsh JA, et al. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 2012;130:1378-86.
    • (2012) Int J Cancer , vol.130 , pp. 1378-1386
    • Heegaard, N.H.1    Schetter, A.J.2    Welsh, J.A.3
  • 82
    • 79953712598 scopus 로고    scopus 로고
    • Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival
    • Silva J, Garcia V, Zaballos A, et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 2011;37:617-23.
    • (2011) Eur Respir J , vol.37 , pp. 617-623
    • Silva, J.1    Garcia, V.2    Zaballos, A.3
  • 83
    • 24944468127 scopus 로고    scopus 로고
    • Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in nonsmall cell lung cancer
    • Cheng TL, Chang MY, Huang SY, et al. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in nonsmall cell lung cancer. Chest 2005;128:1453-60.
    • (2005) Chest , vol.128 , pp. 1453-1460
    • Cheng, T.L.1    Chang, M.Y.2    Huang, S.Y.3
  • 84
    • 84857466158 scopus 로고    scopus 로고
    • Plasma hepatocyte growth factor elevation may be associated with early metastatic disease in primary lung cancer patients
    • Hosoda H, Izumi H, Tukada Y, et al. Plasma hepatocyte growth factor elevation may be associated with early metastatic disease in primary lung cancer patients. Ann Thorac Cardiovasc Surg 2012;18:1-7.
    • (2012) Ann Thorac Cardiovasc Surg , vol.18 , pp. 1-7
    • Hosoda, H.1    Izumi, H.2    Tukada, Y.3
  • 85
    • 84865676436 scopus 로고    scopus 로고
    • Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer
    • Ujiie H, Tomida M, Akiyama H, et al. Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer. Anticancer Res 2012;32:3251-8.
    • (2012) Anticancer Res , vol.32 , pp. 3251-3258
    • Ujiie, H.1    Tomida, M.2    Akiyama, H.3
  • 86
    • 33646843566 scopus 로고    scopus 로고
    • Serum protein expression predicts recurrence in patients with earlystage lung cancer after resection
    • discussion 1987
    • D'Amico TA, Brooks KR, Joshi MB, et al. Serum protein expression predicts recurrence in patients with earlystage lung cancer after resection. Ann Thorac Surg 2006;81:1982-7; discussion 1987.
    • (2006) Ann Thorac Surg , vol.81 , pp. 1982-1987
    • D'Amico, T.A.1    Brooks, K.R.2    Joshi, M.B.3
  • 87
    • 79953147370 scopus 로고    scopus 로고
    • A perspective on cancer cell metastasis
    • Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-64.
    • (2011) Science , vol.331 , pp. 1559-1564
    • Chaffer, C.L.1    Weinberg, R.A.2
  • 88
    • 84873023773 scopus 로고    scopus 로고
    • Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer
    • Ma XL, Xiao ZL, Liu L, et al. Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev 2012;13:1137-44.
    • (2012) Asian Pac J Cancer Prev , vol.13 , pp. 1137-1144
    • Ma, X.L.1    Xiao, Z.L.2    Liu, L.3
  • 89
    • 84907163633 scopus 로고    scopus 로고
    • Circulating tumor cell analysis: technical and statistical considerations for application to the clinic
    • Allan AL, Keeney M. Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010;2010:426218.
    • (2010) J Oncol , vol.2010
    • Allan, A.L.1    Keeney, M.2
  • 90
    • 33847402612 scopus 로고    scopus 로고
    • Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system
    • Riethdorf S, Fritsche H, Muller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13:920-8.
    • (2007) Clin Cancer Res , vol.13 , pp. 920-928
    • Riethdorf, S.1    Fritsche, H.2    Muller, V.3
  • 91
    • 79955045007 scopus 로고    scopus 로고
    • Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer
    • Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011;29:1556-63.
    • (2011) J Clin Oncol , vol.29 , pp. 1556-1563
    • Krebs, M.G.1    Sloane, R.2    Priest, L.3
  • 92
    • 1642580506 scopus 로고    scopus 로고
    • Frequent EpCam protein expression in human carcinomas
    • Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-8.
    • (2004) Hum Pathol , vol.35 , pp. 122-128
    • Went, P.T.1    Lugli, A.2    Meier, S.3
  • 93
    • 79952755005 scopus 로고    scopus 로고
    • Circulating tumor cells as a window on metastasis biology in lung cancer
    • Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 2011;178:989-96.
    • (2011) Am J Pathol , vol.178 , pp. 989-996
    • Hou, J.M.1    Krebs, M.2    Ward, T.3
  • 94
    • 0036595629 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transitions in tumour progression
    • Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-54.
    • (2002) Nat Rev Cancer , vol.2 , pp. 442-454
    • Thiery, J.P.1
  • 95
    • 80052511419 scopus 로고    scopus 로고
    • A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
    • Farace F, Massard C, Vimond N, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 2011;105:847-53.
    • (2011) Br J Cancer , vol.105 , pp. 847-853
    • Farace, F.1    Massard, C.2    Vimond, N.3
  • 96
    • 0033891393 scopus 로고    scopus 로고
    • Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells
    • Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 2000;156:57-63.
    • (2000) Am J Pathol , vol.156 , pp. 57-63
    • Vona, G.1    Sabile, A.2    Louha, M.3
  • 97
    • 84858335921 scopus 로고    scopus 로고
    • Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches
    • Krebs MG, Hou JM, Sloane R, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches. J Thorac Oncol 2012;7:306-15.
    • (2012) J Thorac Oncol , vol.7 , pp. 306-315
    • Krebs, M.G.1    Hou, J.M.2    Sloane, R.3
  • 98
    • 79960922914 scopus 로고    scopus 로고
    • Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method
    • Hofman V, Ilie MI, Long E, et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer 2011;129:1651-60.
    • (2011) Int J Cancer , vol.129 , pp. 1651-1660
    • Hofman, V.1    Ilie, M.I.2    Long, E.3
  • 99
    • 79951849235 scopus 로고    scopus 로고
    • Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker
    • Hofman V, Bonnetaud C, Ilie MI, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2011;17:827-35.
    • (2011) Clin Cancer Res , vol.17 , pp. 827-835
    • Hofman, V.1    Bonnetaud, C.2    Ilie, M.I.3
  • 100
    • 34248397229 scopus 로고    scopus 로고
    • Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method
    • Sawabata N, Okumura M, Utsumi T, et al. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg 2007;55:189-92.
    • (2007) Gen Thorac Cardiovasc Surg , vol.55 , pp. 189-192
    • Sawabata, N.1    Okumura, M.2    Utsumi, T.3
  • 101
    • 58149156672 scopus 로고    scopus 로고
    • Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer
    • Yie SM, Lou B, Ye SR, et al. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer 2009;63:284-90.
    • (2009) Lung Cancer , vol.63 , pp. 284-290
    • Yie, S.M.1    Lou, B.2    Ye, S.R.3
  • 103
    • 84878373665 scopus 로고    scopus 로고
    • Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies
    • Huang LN, Wang DS, Chen YQ, et al. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies. Mol Biol Rep 2013;40:917-24.
    • (2013) Mol Biol Rep , vol.40 , pp. 917-924
    • Huang, L.N.1    Wang, D.S.2    Chen, Y.Q.3
  • 104
    • 11344259257 scopus 로고    scopus 로고
    • Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes
    • Sher YP, Shih JY, Yang PC, et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 2005;11:173-9.
    • (2005) Clin Cancer Res , vol.11 , pp. 173-179
    • Sher, Y.P.1    Shih, J.Y.2    Yang, P.C.3
  • 105
    • 0036675581 scopus 로고    scopus 로고
    • Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study
    • Yamashita J, Matsuo A, Kurusu Y, et al. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg 2002;124:299-305.
    • (2002) J Thorac Cardiovasc Surg , vol.124 , pp. 299-305
    • Yamashita, J.1    Matsuo, A.2    Kurusu, Y.3
  • 106
    • 78650942408 scopus 로고    scopus 로고
    • TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients
    • Yoon SO, Kim YT, Jung KC, et al. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer 2011;71:209-16.
    • (2011) Lung Cancer , vol.71 , pp. 209-216
    • Yoon, S.O.1    Kim, Y.T.2    Jung, K.C.3
  • 107
    • 0036674501 scopus 로고    scopus 로고
    • Dissemination and growth of cancer cells in metastatic sites
    • Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
    • (2002) Nat Rev Cancer , vol.2 , pp. 563-572
    • Chambers, A.F.1    Groom, A.C.2    MacDonald, I.C.3
  • 108
    • 65649084201 scopus 로고    scopus 로고
    • Circulating tumor cells in pulmonary venous blood of primary lung cancer patients
    • Okumura Y, Tanaka F, Yoneda K, et al. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg 2009;87:1669-75.
    • (2009) Ann Thorac Surg , vol.87 , pp. 1669-1675
    • Okumura, Y.1    Tanaka, F.2    Yoneda, K.3
  • 109
    • 79960209024 scopus 로고    scopus 로고
    • Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications
    • Funaki S, Sawabata N, Nakagiri T, et al. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. Eur J Cardiothorac Surg 2011;40:322-7.
    • (2011) Eur J Cardiothorac Surg , vol.40 , pp. 322-327
    • Funaki, S.1    Sawabata, N.2    Nakagiri, T.3
  • 110
    • 0037385741 scopus 로고    scopus 로고
    • Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance
    • Sienel W, Seen-Hibler R, Mutschler W, et al. Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance. Eur J Cardiothorac Surg 2003;23:451-6.
    • (2003) Eur J Cardiothorac Surg , vol.23 , pp. 451-456
    • Sienel, W.1    Seen-Hibler, R.2    Mutschler, W.3
  • 111
    • 0036754172 scopus 로고    scopus 로고
    • Hematogenous dissemination of lung cancer cells during surgery: quantitative detection by flow cytometry and prognostic significance
    • Dong Q, Huang J, Zhou Y, et al. Hematogenous dissemination of lung cancer cells during surgery: quantitative detection by flow cytometry and prognostic significance. Lung Cancer 2002;37:293-301.
    • (2002) Lung Cancer , vol.37 , pp. 293-301
    • Dong, Q.1    Huang, J.2    Zhou, Y.3
  • 112
    • 84860321876 scopus 로고    scopus 로고
    • CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood
    • Franco R, Pirozzi G, Scala S, et al. CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood. Eur J Cardiothorac Surg 2012;41:368-75.
    • (2012) Eur J Cardiothorac Surg , vol.41 , pp. 368-375
    • Franco, R.1    Pirozzi, G.2    Scala, S.3
  • 113
    • 0031816092 scopus 로고    scopus 로고
    • The sequence of vessel ligation affects tumor release into the circulation
    • Kurusu Y, Yamashita J, Hayashi N, et al. The sequence of vessel ligation affects tumor release into the circulation. J Thorac Cardiovasc Surg 1998;116:107-13.
    • (1998) J Thorac Cardiovasc Surg , vol.116 , pp. 107-113
    • Kurusu, Y.1    Yamashita, J.2    Hayashi, N.3
  • 114
    • 31344474247 scopus 로고    scopus 로고
    • Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptasepolymerase chain reaction in peroperative period
    • Ge MJ, Shi D, Wu QC, et al. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptasepolymerase chain reaction in peroperative period. J Cancer Res Clin Oncol 2006;132:248-56.
    • (2006) J Cancer Res Clin Oncol , vol.132 , pp. 248-256
    • Ge, M.J.1    Shi, D.2    Wu, Q.C.3
  • 115
    • 84886566235 scopus 로고    scopus 로고
    • The impact of the sequence of pulmonary vessel ligation during anatomic resection for lung cancer on long-term survival-a prospective randomized trial
    • Kozak A, Alchimowicz J, Safranow K, et al. The impact of the sequence of pulmonary vessel ligation during anatomic resection for lung cancer on long-term survival-a prospective randomized trial. Adv Med Sci 2013;58:156-63.
    • (2013) Adv Med Sci , vol.58 , pp. 156-163
    • Kozak, A.1    Alchimowicz, J.2    Safranow, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.